ClinConnect ClinConnect Logo
Search / Trial NCT06878430

Reducing Risk of Stroke and DementIa in PatientS with COVert CERebrovascular Disease

Launched by UNIVERSITY OF EDINBURGH · Mar 13, 2025

Trial Information

Current as of April 23, 2025

Not yet recruiting

Keywords

Ccd

ClinConnect Summary

DISCOVER is a prospective cohort involving individuals with covert cerebrovascular disease (CCD) in NHS Lothian. Participants will be recruited through electronic health records and clinician collaborators. Participants will be monitored at 3 and 6 months and where possible 12 months to assess cognitive, functional, and vascular event outcomes.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • People who, at the time the letter is prepared or are identified by a clinician
  • Age ≥ 65 years
  • * Have no known history of:
  • Stroke or TIA
  • Dementia
  • Parkinson's disease
  • Multiple sclerosis
  • Metastatic cancer (or non-meningioma brain tumour).
  • * A CT or MRI scan report ≤5 years before study start date with of one or more of:
  • Cerebral small vessel disease
  • Deep old ischaemic stroke
  • Cortical old ischaemic stroke
  • Exclusion Criteria:
  • Text of brain scan report unreadable
  • Do not consent to take part in study procedures
  • Unable to consent
  • Unable to communicate by email, letter or telephone through language, speech disability or lack of address
  • Unlikely to survive one year past enrolment in judgement of the study investigator

About University Of Edinburgh

The University of Edinburgh, a prestigious institution renowned for its commitment to research excellence and innovation, serves as a leading clinical trial sponsor dedicated to advancing healthcare through rigorous scientific inquiry. With a strong emphasis on multidisciplinary collaboration, the university facilitates cutting-edge clinical studies that aim to explore novel therapies and improve patient outcomes. Leveraging its extensive network of researchers, healthcare professionals, and state-of-the-art facilities, the University of Edinburgh is at the forefront of translating scientific discoveries into practical applications, thereby contributing significantly to the global medical community.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported